All In MedTech

FDA Clearance Tracker · P970003-S032

NEUROCYBERNETIC PROSTHESIS (NCP) SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 10, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 10, 2001

Approved

Time to decision

48 days

Received Mar 23, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970003-S032
Device name
NEUROCYBERNETIC PROSTHESIS (NCP) SYSTEM
Applicant location
Houston, TX
Received
Mar 23, 2001
Decided
May 10, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P970003

Device type

Device class
Class III

Every decision under product code LYJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A NEW STERILIZATION SITE LOCATED AT STERITEC, INC., ATHENS, TEXAS, AS WELL AS LABELING PROCESS AND PACKAGING CHANGES, AND A COMBINED MODEL PHYSICIAN'S MANUAL.

Source documents

Other decisions for LivaNova USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.